InvestorsHub Logo
Followers 67
Posts 3213
Boards Moderated 0
Alias Born 06/16/2016

Re: None

Friday, 02/17/2017 6:36:05 AM

Friday, February 17, 2017 6:36:05 AM

Post# of 32853
USRM- U.S. STEM CELL, INC. MYOCELL. Currently FDA Approved in phase 2/3.

Buyout possibly looming but being held up by court case. Do your DD.

Another clinic may be opening from a Facebook post by someone in training at us stem cell that lives in New Jersey.

A lot of catalysts that could be coming here. Dilution has seem to be very minimum. Market cap is around 300k. So low! Competition in stem cell is around 1.00 pps and this is at .0037. Many strong hands holding USRM.

A world leader in research and development of stem cell and regenerative medicine treatments for patients with degenerative conditions. Pioneered new applications for diseases and developed more than 30 protocols.
http://us-stemcell.com/en/products/

U.S. STEM CELL, INC. provides accredited training programs in regenerative medicine to physicians throughout the world.
https://www.usstemcelltraining.com/

Stem cell peers 1.00 PPS +!
See for yourself -cc'd from HH (thanks HH):
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128248827&txt2find=regenerative

US STEM CELL, INC. personal testimonial:


Stem cell market and info.:
https://singularityhub.com/2017/01/17/stem-cells-are-poised-to-change-health-and-medicine-forever/




Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.